← All trials
NCT00402610
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 1994
- Primary completion
- —
- Completion date
- Dec 1, 1998
- First posted
- —
- Last posted
- —
- Enrollment
- 332
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Sociedad Andaluza de Enfermedades InfecciosasLead sponsor
- Universidad Carlos III MadridOverall official - principal investigator
- Hospital Universitario Virgen de las NievesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.